Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) biomarkers. This review
focuses on the biological characteristics of lncRNA and its value as a biomarker
Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) for intermediate-risk PCa, aiming to selectively
target localized cancerous lesions while preserving healthy tissue
of various cancers, notably HCC. A major
focus in recent studies has been on the epigenetic regulation of mi
Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) promising
targets for suppression of ventricular arrhythmias. Accordingly, we report the different roles
. This is due to the onesided
focus of strategies in the search for mechanisms of these SNPs influence, which
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) and genomics have enabled the identification of specific molecular pathways and
targets, paving the way
parameters of carcinogenesis and therapy resistance, with a
focus on solid cancers of non-infectious etiology
current knowledge on promising lncRNAs as biomarkers and therapeutic
targets for IS exploring original